# Boston Scientific

Type: Company (BSX)

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/boston-scientific
Canonical HTML page: https://getlegalbrief.com/entity/boston-scientific

## Timeline

- **2026-03-23**: Secondary Notice — Pomerantz reinforces the filing highlights to ensure broad investor awareness.
- **2026-03-22**: Initial Legal Notice — Pomerantz LLP issues the first public call for shareholders to join the class action.
- **2026-02-23**: SEC 8-K Filing — BSX files a Form 8-K under Item 8.01 (Other Events), potentially triggering market reaction.
- **2026-02-04**: Earnings Report — Boston Scientific reports Q4 2025 financial results and provides 2026 guidance.

## Recent coverage (1 stories)

### Pomerantz LLP Initiates Securities Class Action Against Boston Scientific
2026-03-23 23:31:37 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pomerantz LLP has issued a formal notice regarding a class action lawsuit against Boston Scientific Corporation (BSX), alleging potential securities fraud. The litigation focuses on whether the medical technology giant made misleading statements regarding its product pipeline or regulatory compliance during the class period.
Full story: https://getlegalbrief.com/story/pomerantz-llp-boston-scientific-class-action-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.